AstraZeneca has named Hennie Frick as Executive Director, Program Lead and Site Lead for Virginia. Frick joins as the company advances a new $4.5 billion manufacturing facility at Rivanna Futures near Charlottesville in Albemarle County, the cornerstone of its $50 billion U.S. investment in research, development, and manufacturing.
About Hennie Frick
Frick joins AstraZeneca after nearly 25 years at GSK, most recently as Vice President of Global GMP Operations Clinical Supply Chain. Before that, Frick spent a decade as Pilot Plant Site Director for GSK’s R&D pilot plant in Jurong, having started there as the pilot plant’s engineering manager. A chemical engineer by training, Frick earlier held process engineering and design roles at GSK’s Irvine site and in the specialty chemicals industry.
Frick holds a bachelor’s degree in chemical engineering from the University of Pretoria and a master’s degree in bioreactor systems from the University of Manchester.
About AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolic, and respiratory and immunology therapies.
